Perspectives between clinical trials sponsors and CROs

Clinical trial sponsors and contract research organizations (CRO) are working together to find a balance between the level of micromanagement and the quality of trials. Outsourcing-Pharma.com’s Zachary Brennan reports that recent studies found that only 41% of sponsors felt they could achieve quality trials without increased oversight, however, sponsors still want less micromanagement. Another tension in the relationship between CROs and sponsors is the amount of risk involved. Christopher Hilton, vice president of development and clinical alliance manager at Pfizer comments, “at the end of the day, CROs talk about wanting skin in the game and risk-sharing, but if we screw up at Pfizer and lose $2 billion, they aren’t going to share in that risk.” Acting division director of good clinical compliance for the US FDA, Anne Meeker-O’Connell, believe that clarity between the two sides can solve most issues. To read the full perspective click here.